Literature DB >> 3942692

Changes in fluidity and composition of erythrocyte membranes and in composition of plasma lipids in type I diabetes.

M Bryszewska, C Watała, W Torzecka.   

Abstract

Changes in the fluidity and composition of human erythrocyte membranes and in the composition of plasma in Type I (insulin-dependent) diabetes were investigated. The increased microviscosity of diabetic erythrocyte membranes provide unambiguous proof of the structural deterioration of erythrocyte membranes in diabetes. It seems most likely that enhancement of the membrane cholesterol/phospholipid ratio is the main reason for decreased membrane fluidity in diabetes. A distinct correlation between membrane cholesterol/phospholipid ratio, plasma cholesterol content and membrane fluidity was found. Composition and structural changes in erythrocyte membranes and compositional changes in plasma lipids may contribute to the development of diabetic complications in diabetes.

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3942692     DOI： 10.1111/j.1365-2141.1986.tb02906.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


  15 in total

1.  Evaluation of the effect of n-3 PUFA-rich dietary fish oils on lipid profile and membrane fluidity in alloxan-induced diabetic mice (Mus musculus).

Authors:  Shantal Ganapati Kamat; Ramaballav Roy
Journal:  Mol Cell Biochem       Date:  2016-04-21       Impact factor: 3.396

2.  Selective LXR agonist DMHCA corrects retinal and bone marrow dysfunction in type 2 diabetes.

Authors:  Cristiano P Vieira; Seth D Fortmann; Masroor Hossain; Ana Leda Longhini; Sandra S Hammer; Bright Asare-Bediako; David K Crossman; Micheli S Sielski; Yvonne Adu-Agyeiwaah; Mariana Dupont; Jason L Floyd; Sergio Li Calzi; Todd Lydic; Robert S Welner; Gary J Blanchard; Julia V Busik; Maria B Grant
Journal:  JCI Insight       Date:  2020-07-09

3.  Assessment of erythrocyte shape by flow cytometry techniques.

Authors:  M Piagnerelli; K Zouaoui Boudjeltia; D Brohee; A Vereerstraeten; P Piro; J-L Vincent; M Vanhaeverbeek
Journal:  J Clin Pathol       Date:  2006-06-14       Impact factor: 3.411

Review 4.  Red Blood Cell Function and Dysfunction: Redox Regulation, Nitric Oxide Metabolism, Anemia.

Authors:  Viktoria Kuhn; Lukas Diederich; T C Stevenson Keller; Christian M Kramer; Wiebke Lückstädt; Christina Panknin; Tatsiana Suvorava; Brant E Isakson; Malte Kelm; Miriam M Cortese-Krott
Journal:  Antioxid Redox Signal       Date:  2017-01-18       Impact factor: 8.401

5.  Alterations in acetylcholinesterase and butyrylcholinesterase activities in chronic obstructive pulmonary disease: relationships with oxidative and inflammatory markers.

Authors:  Amel Ben Anes; Hela Ben Nasr; Abdelhamid Garrouch; Sarra Bennour; Sarra Bchir; Mohamed Hachana; Mohamed Benzarti; Zouhair Tabka; Karim Chahed
Journal:  Mol Cell Biochem       Date:  2017-12-12       Impact factor: 3.396

6.  Fatty acid uptake in diabetic rat adipocytes.

Authors:  H Fraser; S M Coles; J K Woodford; A A Frolov; E J Murphy; F Schroeder; D A Bernlohr; V Grund
Journal:  Mol Cell Biochem       Date:  1997-02       Impact factor: 3.396

7.  Correction by insulin added in vitro of abnormal membrane fluidity of the erythrocytes from type 1 (insulin-dependent) diabetic patients.

Authors:  I Juhan-Vague; D Rahmani-Jourdheuil; Z Mishal; C Roul; Y Mourayre; M F Aillaud; P Vague
Journal:  Diabetologia       Date:  1986-07       Impact factor: 10.122

8.  Analysis of membrane fluidity alterations and lipid disorders in type I diabetic children and adolescents.

Authors:  C Watała; M Kordacka; A Loba; Z Jóźwiak; S Nowak
Journal:  Acta Diabetol Lat       Date:  1987 Apr-Jun

9.  Effect of phospholipase treatment on insulin receptor signal transduction.

Authors:  G Zoppini; C R Kahn
Journal:  Diabetologia       Date:  1992-02       Impact factor: 10.122

10.  Advanced glycosylation end products (AGEs), insulin-like growth factor-1 (IGF-1) and IGF-binding protein-3 (IGFBP-3) in patients with type 2 diabetes mellitus.

Authors:  M E Garay-Sevilla; L E Nava; J M Malacara; K Wróbel; K Wróbel; U Pérez
Journal:  Diabetes Metab Res Rev       Date:  2000 Mar-Apr       Impact factor: 8.128
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.